Research ArticleORIGINAL RESEARCH
Open Access

In Vitro Lymphocyte Functions in Undernourished Children With Sickle Cell Anemia

Solo R. Kuvibidila, Renée Gardner, Maria C. Velez, Lolie Yu and Rajasekharan P. Warrier
Ochsner Journal June 2020, 20 (2) 151-160; DOI: https://doi.org/10.31486/toj.19.0024

REFERENCES

  1. 1.↵
    1. Cohen S,
    2. Danzaki K,
    3. Maclver NJ
    . Nutritional effects on T-cell immunometabolism. Eur J Immunol. 2017 Feb;47(2):225-235. doi: 10.1002/eji.201646423.
    OpenUrlCrossRef
  2. 2.
    1. Ibrahim MK,
    2. Zambruni M,
    3. Melby CL,
    4. Melby PC
    . Impact of childhood malnutrition on host defense and infection. Clin Microbiol Rev. 2017 Oct;30(4):919-971. doi: 10.1128/CMR.00119-16.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Calder PC,
    2. Field CJ,
    3. Gill H
    1. Cunningham-Rundles S
    . Evaluation of the effects of nutrients on immune function. In: Calder PC, , Field CJ, , Gill H, eds. Nutrition and Immune Function. Wallingford, UK: CABI Publishing, The Nutrition Society; 2002:21-39.
  4. 4.↵
    1. Rytter MJ,
    2. Kolte L,
    3. Briend A,
    4. Friis H,
    5. Christensen VB
    . The immune system in children with malnutrition—a systematic review. PLoS One. 2014 August 25;9(8):e105017. doi: 10.1371/journal.pone.0105017.
    OpenUrlCrossRefPubMed
  5. 5.
    1. Zemel BS,
    2. Kawchak DA,
    3. Ohene-Frempong K,
    4. Schall JI,
    5. Stallings VA
    . Effects of delayed pubertal development, nutritional status, and disease severity on longitudinal patterns of growth failure in children with sickle cell disease. Pediatr Res. 2007 May;61(5 Pt 1):607-613. doi: 10.1203/pdr.0b013e318045bdca.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.
    1. Bennett EL
    . Understanding growth failure in children with homozygous sickle-cell disease. J Pediatr Oncol Nurs. 2011 Mar-Apr;28(2):67-74. doi: 10.1177/1043454210382421.
    OpenUrlCrossRefPubMed
  7. 7.
    1. Al-Saqladi AW,
    2. Cipolotti R,
    3. Fijnvandraat K,
    4. Brabin BJ
    . Growth and nutritional status of children with homozygous sickle cell disease. Ann Trop Paediatr. 2008 Sep;28(3):165-189. doi: 10.1179/146532808X335624.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Singhal A,
    2. Thomas P,
    3. Cook R,
    4. Wierenga K,
    5. Serjeant G
    . Delayed adolescent growth in homozygous sickle cell disease. Arch Dis Child. 1994 Nov;71(5):404-408. doi: 10.1136/adc.71.5.404.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Balandya E,
    2. Reynolds T,
    3. Obaro S,
    4. Makani J
    . Alteration of lymphocyte phenotype and function in sickle cell anemia: implications for vaccine responses. Am J Hematol. 2016 Sep;91(9):938-946. doi: 10.1002/ajh.24438.
    OpenUrlCrossRef
  10. 10.↵
    1. Hyacinth HI,
    2. Gee BE,
    3. Hibbert JM
    . The role of nutrition in sickle cell disease. Nutr Metab Insights. 2010 Jan 1;3:57-67. doi: 10.4137/NMI.S5048.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Khan SA,
    2. Damanhouri G,
    3. Ali A,
    4. et al.
    Precipitating factors and targeted therapies in combating the perils of sickle cell disease—a special nutritional consideration. Nutr Metab (Lond). 2016 Aug 8;13:50. doi: 10.1186/s12986-016-0109-7.
    OpenUrlCrossRef
  12. 12.↵
    1. Hibbert JM,
    2. Hsu LL,
    3. Bhathena SJ,
    4. et al.
    Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease. Exp Biol Med (Maywood). 2005 Jan;230(1):68-74. doi: 10.1177/153537020523000109.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Martyres DJ,
    2. Vijenthira A,
    3. Barrowman N,
    4. Harris-Janz S,
    5. Chretien C,
    6. Klaassen RJ
    . Nutrient insufficiencies/deficiencies in children with sickle cell disease and its association with increased disease severity. Pediatr Blood Cancer. 2016 Jun;63(6):1060-1064. doi: 10.1002/pbc.25940.
    OpenUrlCrossRef
  14. 14.↵
    1. Zemel BS,
    2. Kawchak DA,
    3. Fung EB,
    4. Ohene-Frepong K,
    5. Stallings VA
    . Effect of zinc supplementation on growth and body composition in children with sickle cell disease. Am J Clin Nutr. 2002 Feb;75(2):300-307. doi: 10.1093/ajcn/75.2.300.
    OpenUrlAbstract/FREE Full Text
  15. 15.
    1. Hasanato RM
    . Zinc and antioxidant vitamin deficiency in patients with sickle cell anemia. Ann Saudi Med. 2006 Jan-Feb;26(1):17-21. doi: 10.5144/0256-4947.2006.17.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Prasad AS,
    2. Beck FW,
    3. Kaplan J,
    4. et al.
    Effect of zinc supplementation on incidence of infections and hospital admissions in sickle cell disease (SCD). Am J Hematol. 1999 Jul;61(3):194-202. doi: 10.1002/(sici)1096-8652(199907)61:3<194::aid-ajh6>3.0.co;2-c.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Heyman MB,
    2. Vichinsky E,
    3. Katz R,
    4. et al.
    Growth retardation in sickle cell disease treated by nutritional support. Lancet. 1985 Apr 20;1(8434):903-906. doi: 10.1016/s0140-6736(85)91677-0.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Kuvibidila S,
    2. Gardner R,
    3. Ode D,
    4. Yu L,
    5. Lane G,
    6. Warrier RP
    . Tumor necrosis factor alpha in children with sickle cell disease in stable condition. J Natl Med Assoc. 1997 Sep;89(9):609-615.
    OpenUrlPubMed
  19. 19.↵
    1. Kuvibidila S,
    2. Gardner R,
    3. Velez M,
    4. Warrier R
    . Clinical observations, plasma retinol concentrations, and in vitro lymphocyte functions in children with sickle cell disease. Ochsner J. 2018 Winter;18(4):308-317. doi: 10.31486/TOJ.17.0044.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Warrier RP,
    2. Kuvibidila S,
    3. Gordon L,
    4. Humbert J
    . Transport proteins and acute phase reactant proteins in children with sickle cell anemia. J Natl Med Assoc. 1994 Jan;86(1):33-39. Erratum in: J Natl Med Assoc. 1994 Jul;86(7):515.
    OpenUrlPubMed
  21. 21.↵
    1. Kuvibidila SR,
    2. Sandoval M,
    3. Lao J,
    4. et al.
    Plasma zinc levels inversely correlate with vascular cell adhesion molecule-1 concentration in children with sickle cell disease. J Natl Med Assoc. 2006 Aug;98(8):1263-1272.
    OpenUrlPubMed
  22. 22.↵
    1. Quinn CT
    . Minireview: clinical severity in sickle cell disease: the challenges of definition and prognostication. Exp Biol Med (Maywood). 2016 Apr;241(7):679-688. doi: 10.1177/1535370216640385.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Gibson SR
    1. Gibson SR
    . Assessment of protein status. In: Gibson SR, ed. Principles of Nutritional Assessment. 2nd ed. New York, NY: Oxford University Press; 2005:403-442.
  24. 24.↵
    1. Beck KF,
    2. Rosenthal TC
    . Prealbumin: a marker for nutritional evaluation. Am Fam Physician. 2002 Apr 15;65(8):1575-1578. Erratum in: Am Fam Physician. 2002 Dec 15;66(12):2208.
    OpenUrlPubMedWeb of Science
  25. 25.↵
    C-reactive protein concentrations as a marker of inflammation or infection for interpreting biomarkers of micronutrient status. World Health Organization. www.who.int/nutrition/publications/micronutrients/indicators_c-reactive_protein/en/. Published 2014.
  26. 26.↵
    1. Thurnham DI,
    2. McCabe GP
    . Influence of infection and inflammation on biomarkers of nutritional status with an emphasis on vitamin A and iron. World Health Organization Report: priorities in the assessment of vitamin A and iron status in populations. www.who.int/nutrition/publications/micronutrients/background_paper4_report_assessment_vitAandIron_status.pdf. Published 2012.
  27. 27.↵
    1. Zito DR,
    2. Johnson KL,
    3. Skipper ME,
    4. Normansell DE
    . Isolation of mononuclear cells from whole blood: comparison of two media. Lab Medicine. 1986 Feb 1;17(2):94-95.
    OpenUrl
  28. 28.↵
    1. Hank JA,
    2. Surfus J,
    3. Gan J,
    4. et al.
    Distinct clinical and laboratory activity of two recombinant interleukin-2 preparations. Clin Cancer Res. 1999 Feb;5(2):281-289.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Munro HB,
    2. Page IB
    1. Munro HB
    . Differences among group means: one way analysis of variance. In: Munro HB, , Page IB, eds. Statistical Methods for Health Care Research. 2nd ed. Philadelphia, PA: JB Lippincott Company; 1993:99-128.
  30. 30.↵
    1. Taylor S,
    2. Shacks S,
    3. Villicana S,
    4. Olivares J,
    5. Dinkins G
    . Lymphocyte blastogenic responses in sickle cell disease. Immunol Invest. 1991 Dec;20(7):645-655. doi: 10.3109/08820139109026244.
    OpenUrlCrossRefPubMed
  31. 31.
    1. Taylor SC,
    2. Shacks SJ,
    3. Mitchell RA
    . In vitro lymphocyte blastogenic responses and cytokine production in sickle cell disease patients with acute pneumonia. Pediatr Infect Dis J. 1996 Apr;15(4):340-344. doi: 10.1097/00006454-199604000-00011.
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    1. Taylor S,
    2. Shacks S,
    3. Qu Z,
    4. Colaco V
    . In vitro suppression of the normal mitogenic T lymphocyte response by steady state sickle cell disease sera. Immunol Invest. 1997 Aug-Dec; 26(5-7):561-568. doi: 10.3109/08820139709088540.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Macian F
    . NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol. 2005 Jun;5(6):472-484. doi: 10.1038/nri1632.
    OpenUrlCrossRefPubMedWeb of Science
  34. 34.↵
    1. Serjeant GR
    . The natural history of sickle cell disease. Cold Spring Harb Perspect Med. 2013 Oct 1;3(10):a011783. doi: 10.1101/cshperspect.a011783.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords